Comparison of Quadruple Induction Including ATG or IL-2R Antibody With FK506-Based Therapy After Liver Transplantation

By Langrehr J.M.   Schneller A.   Guckelberger O.   Lohmann R.   Neumann U.   Jonas S.   Klupp J.   Settmacher U.   Knoop M.   Bechstein W.O.   Neuhaus P.J.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1439-1440

Elsevier

Access to resources Recommend Favorite

Rescue FK506 Therapy for Acute Rejection and Early Chronic Rejection After Liver Transplantation: Report of 14 Cases

By Taibi A.   Adham M.   Ducerf C.   Chevallier M.   Bizollon T.   Delaroche E.   Aljuaid N.   Berthoux N.   Baulieux J.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1411-1412

Elsevier

Access to resources Recommend Favorite

Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563

By Langrehr J.M.   Lohmann R.   Raakow R.   Jonas S.   Klupp J.   Bechstein W.O.   Neuhaus R.   Neuhaus P.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2290-2291

Elsevier

Access to resources Recommend Favorite

A Randomized Clinical Trial Using ATG Fresenius or ATG Merieux as Induction Therapy in Kidney Transplantation

By Norrby J.   Olausson M.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 3135-3136

Elsevier

Access to resources Recommend Favorite

Low rejection rate with high-dose ATG bolus therapy in simultaneous pancreas and kidney transplantation

By Saudek F.   Adamec M.   Koznarova R.   Jedinakova T.   Boucek P.   Voska L.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2304-2306

Elsevier

Access to resources Recommend Favorite